The sequencing, analysis and interpretation of the human genome, which leads to therapeutic, diagnostic and wellness applications.
This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!
Research Brief | August 02, 2018
Direct‑to‑consumer (DTC) genetic testing (GT) companies have been around for more than a decade, with 23andMe kickstarting the personal genomics era in 2006. Since then, more than 200 DTC GT companies have appeared, offering health and wellness, fitness, nutrition, and ancestry services. ... Not part of subscription
Research Brief | August 28, 2018
Two out of every three people on this planet live in Asia. This doesn't even include the ethnic Asians living elsewhere or those of mixed ancestries. Interestingly, genomic efforts have hardly kept up with this demographic reality. In fact, Asian genomic data is scarce, with over 80% of genomic data... Not part of subscription
News Commentary | August 29, 2018
Finnish genetic blockchain startup Timicoin has been receiving huge interest from 23andMe consumers to port over their genetic data. This reflects a growing sentiment of consumer empowerment over their own genetic data, a trend we previously predicted. However, 23andMe has swiftly stepped in to ... Not part of subscription